BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25551558)

  • 41. Interaction between directional epistasis and average mutational effects.
    Wilke CO; Adami C
    Proc Biol Sci; 2001 Jul; 268(1475):1469-74. PubMed ID: 11454290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epistasis between new mutations and genetic background and a test of genetic canalization.
    Elena SF; Lenski RE
    Evolution; 2001 Sep; 55(9):1746-52. PubMed ID: 11681730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How mutational epistasis impairs predictability in protein evolution and design.
    Miton CM; Tokuriki N
    Protein Sci; 2016 Jul; 25(7):1260-72. PubMed ID: 26757214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epistasis can lead to fragmented neutral spaces and contingency in evolution.
    Schaper S; Johnston IG; Louis AA
    Proc Biol Sci; 2012 May; 279(1734):1777-83. PubMed ID: 22158953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Search for the mechanism of genetic variation in the pro gene of human immunodeficiency virus.
    Rouzine IM; Coffin JM
    J Virol; 1999 Oct; 73(10):8167-78. PubMed ID: 10482567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection enhances protein evolvability by increasing mutational robustness and foldability.
    Zheng J; Guo N; Wagner A
    Science; 2020 Dec; 370(6521):. PubMed ID: 33273072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Learning the pattern of epistasis linking genotype and phenotype in a protein.
    Poelwijk FJ; Socolich M; Ranganathan R
    Nat Commun; 2019 Sep; 10(1):4213. PubMed ID: 31527666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A nonadaptive origin of a beneficial trait: in silico selection for free energy of folding leads to the neutral emergence of mutational robustness in single domain proteins.
    Pagan RF; Massey SE
    J Mol Evol; 2014 Feb; 78(2):130-9. PubMed ID: 24362542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amino acid impact factor.
    Sruthi CK; Prakash M
    PLoS One; 2018; 13(6):e0198645. PubMed ID: 29897971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perspective: Evolution and detection of genetic robustness.
    de Visser JA; Hermisson J; Wagner GP; Ancel Meyers L; Bagheri-Chaichian H; Blanchard JL; Chao L; Cheverud JM; Elena SF; Fontana W; Gibson G; Hansen TF; Krakauer D; Lewontin RC; Ofria C; Rice SH; von Dassow G; Wagner A; Whitlock MC
    Evolution; 2003 Sep; 57(9):1959-72. PubMed ID: 14575319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantifying the Mutational Robustness of Protein-Coding Genes.
    Ferrada E
    J Mol Evol; 2021 Jul; 89(6):357-369. PubMed ID: 33934169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A large-scale survey of pairwise epistasis reveals a mechanism for evolutionary expansion and specialization of PDZ domains.
    Nedrud D; Coyote-Maestas W; Schmidt D
    Proteins; 2021 Feb; ():. PubMed ID: 33620761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Latent evolutionary potentials under the neutral mutational drift of an enzyme.
    Amitai G; Gupta RD; Tawfik DS
    HFSP J; 2007 May; 1(1):67-78. PubMed ID: 19404461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.
    Yue L; Pfafferott KJ; Baalwa J; Conrod K; Dong CC; Chui C; Rong R; Claiborne DT; Prince JL; Tang J; Ribeiro RM; Cormier E; Hahn BH; Perelson AS; Shaw GM; Karita E; Gilmour J; Goepfert P; Derdeyn CA; Allen SA; Borrow P; Hunter E
    PLoS Pathog; 2015 Jan; 11(1):e1004565. PubMed ID: 25569444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contribution of recombination to the evolutionary history of HIV.
    Vuilleumier S; Bonhoeffer S
    Curr Opin HIV AIDS; 2015 Mar; 10(2):84-9. PubMed ID: 25565174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers.
    Fukazawa Y; Lum R; Okoye AA; Park H; Matsuda K; Bae JY; Hagen SI; Shoemaker R; Deleage C; Lucero C; Morcock D; Swanson T; Legasse AW; Axthelm MK; Hesselgesser J; Geleziunas R; Hirsch VM; Edlefsen PT; Piatak M; Estes JD; Lifson JD; Picker LJ
    Nat Med; 2015 Feb; 21(2):132-9. PubMed ID: 25599132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV-1 adaptation to HLA: a window into virus-host immune interactions.
    Carlson JM; Le AQ; Shahid A; Brumme ZL
    Trends Microbiol; 2015 Apr; 23(4):212-24. PubMed ID: 25613992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients.
    Ceresola ER; Nozza S; Sampaolo M; Pignataro AR; Saita D; Ferrarese R; Ripa M; Deng W; Mullins JI; Boeri E; Tambussi G; Toniolo A; Lazzarin A; Clementi M; Canducci F
    J Antimicrob Chemother; 2015 May; 70(5):1391-5. PubMed ID: 25608585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1.
    Berger CT; Llano A; Carlson JM; Brumme ZL; Brockman MA; Cedeño S; Harrigan PR; Kaufmann DE; Heckerman D; Meyerhans A; Brander C
    J Virol; 2015 Apr; 89(7):4015-9. PubMed ID: 25589651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.
    Deng K; Pertea M; Rongvaux A; Wang L; Durand CM; Ghiaur G; Lai J; McHugh HL; Hao H; Zhang H; Margolick JB; Gurer C; Murphy AJ; Valenzuela DM; Yancopoulos GD; Deeks SG; Strowig T; Kumar P; Siliciano JD; Salzberg SL; Flavell RA; Shan L; Siliciano RF
    Nature; 2015 Jan; 517(7534):381-5. PubMed ID: 25561180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.